SPLSTARPHARMA HOLDINGS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 03:31 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 19 Aug 2026, 04:02 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 14 Aug 2026, 04:31 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 13 Aug 2026, 20:08 | Change of Director Interest Notice - R Basser | Director Interests | — | 02009 | |
| 13 Aug 2026, 20:07 | Change of Director Interest Notice - R Thomas | Director Interests | — | 02009 | |
| 13 Aug 2026, 20:06 | Change of Director Interest Notice - L Cheng | Director Interests | — | 02009 | |
| 13 Aug 2026, 20:06 | Change of Director Interest Notice - J Davies | Director Interests | — | 02009 | |
| 13 Aug 2026, 20:02 | Change of Director Interest Notice - C Maley | Director Interests | — | 02009 | |
| 12 Aug 2026, 04:37 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 11 Aug 2026, 19:53 | Application for quotation of securities - SPL | Other | — | 06020 | |
| 11 Aug 2026, 19:49 | Successful Completion of $32 million Entitlement Offer | Capital Raising | MS | 06001 | |
| 24 July 2026, 02:21 | Letter to Ineligible Shareholders | Capital Raising | — | 06001, 16002 | |
| 24 July 2026, 02:20 | Letter to Eligible Shareholders | Capital Raising | — | 06001, 16002 | |
| 22 July 2026, 03:50 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 17 July 2026, 19:36 | Entitlement Offer Booklet | Capital Raising | — | 06001, 06010 | |
| 15 July 2026, 19:25 | Cleansing Notice | Securities Administration | — | 06018 | |
| 15 July 2026, 19:20 | Proposed issue of securities - SPL | Securities Administration | — | 06013 | |
| 15 July 2026, 19:15 | Entitlement Offer Investor Presentation | Presentations | MS | 03026 | |
| 15 July 2026, 19:10 | Fully Underwritten Entitlement Offer to Raise $32 Million | Capital Raising | MS | 06001 | |
| 15 July 2026, 19:03 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 8 July 2026, 01:26 | DEP HER2 Investor Webinar | Presentations | — | 03026 | |
| 3 July 2026, 19:29 | DEP milestone triggers partner option fee | Company Update | MS | 11001 | |
| 2 July 2026, 19:22 | Positive DEP HER2-Lu preclinical data support Phase 1 entry | Company Update | MS | 11001 | |
| 2 July 2026, 19:20 | DEP radiopharmaceutical data supports patent application | Company Update | MS | 11001 | |
| 24 June 2026, 04:06 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 17 June 2026, 18:28 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 29 Apr 2026, 20:15 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 21 Apr 2026, 19:40 | FDA confirms path to DEP HER2 first-in-human study | Company Update | MS | 11001 | |
| 15 Apr 2026, 18:24 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 7 Apr 2026, 18:32 | Application for quotation of securities - SPL | Other | — | 06020 | |
| 13 Mar 2026, 00:29 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 4 Mar 2026, 07:04 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 18 Feb 2026, 19:37 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 18 Feb 2026, 19:10 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 11 Feb 2026, 02:42 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 10 Feb 2026, 19:17 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 29 Jan 2026, 21:01 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 8 Jan 2026, 00:03 | Application for quotation of securities - SPL | Other | — | 06020 | |
| 7 Jan 2026, 23:58 | Notification of cessation of securities - SPL | Other | — | 06027 | |
| 18 Dec 2025, 01:14 | Change of Director's Interest Notice - C Maley | Director Interests | — | 02009 | |
| 18 Dec 2025, 01:06 | Notification regarding unquoted securities - SPL | Other | — | 06021 | |
| 15 Nov 2025, 03:18 | Results of 2025 Annual General Meeting | Meetings & Governance | — | 08003 | |
| 15 Nov 2025, 00:05 | AGM Chair address and CEO presentation | Presentations | MS | 03026, 15002 | |
| 28 Oct 2025, 19:55 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 22 Oct 2025, 21:25 | Upfront payment of USD $5.5 million received from Genentech | Company Update | MS | 11001 | |
| 22 Oct 2025, 02:30 | Australian Microcap Investment Conference presentation | Presentations | — | 03026 | |
| 21 Oct 2025, 22:51 | Change of Director's Interest Notice - R Thomas | Director Interests | — | 02009 | |
| 13 Oct 2025, 20:29 | Notice of 2025 Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 6 Oct 2025, 20:57 | Change of Director's Interest Notice - C Maley | Director Interests | — | 02009 | |
| 6 Oct 2025, 20:50 | Notification of cessation of securities - SPL | Other | — | 06027 |
1–50 of 60
1 / 2